The New York Entrepreneur

New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle

Read Time:6 Second

Breakthrough sickle cell treatments are available in the U.S., but their high cost is forcing insurers to get creative.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Here’s why Citi analysts think banks will avoid commercial-real-estate losses
Next post To save Social Security, they may come for your 401(k)